metabolic syndrome. Metabolic disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: waist circumference men = 102cm or 40in and women = 88cm or 35in; fasting blood glucose = 110 mg per dl; HDL cholesterol for men < 40 mg per dl and for women < 50 mg per dl; triglycerides = 150 mg per dl; blood pressure = 130 and 85 mm Hg Exclusion criteria: hypothyroidism; alcoholism; smoking; auto immune disease; chronic pancreatitis; liver dysfunction; kidney disorder or nephritic syndrome; simultaneous subscription in other interventional study; any inflammatory disease or incidence of infection at start or during the study period; consumption of other drug such as aspirin or any NSAID; propranolol; any form of steroids and any kind of lipid lowering agent; angioplasty or heart attack positive history; pregnancy and lactating
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure (systolic and diastolic). Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Beurer upper arm digital blood pressure monitor.;Fasting Blood Glucose. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;Triglyceride. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;HDL-cholesterol. Timepoint: Begining of study first day and at the end of study 49th. Method of measurement: Laboratory kit, Pars Azmoon.;Waist circumference. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: By measure tape least circumference between last rib and iliac crest.;LDL-cholesterol. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;MDA. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Reaction serum MDA with tiobarbituric acid, measure absorption with florimetry and comparison with standard curve. | — |
Countries
Iran (Islamic Republic of)
Contacts
School of Nutrition, Shiraz University of Medical Sciences